GlassScriptPhysician profile
Narinder K Sandhu
NPI 1194021741
$1,662.30
in general payments reported to CMS, 2019-2025
24 companies · $12.97 in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,153 · 2020: $477 · 2023: $1.78 · 2024: $17.95 · 2025: $12.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $32.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $32.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $392.24 | 2019-2020 | |
| Lilly USA, LLC | $265.58 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $201.61 | 2019-2020 | |
| Amgen INC. | $102.55 | 2019 | |
| Sanofi-Aventis U.S. LLC | $98.27 | 2019-2020 | |
| Corcept Therapeutics | $75.66 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.00 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $55.96 | 2019-2020 | |
| Novo Nordisk INC | $53.19 | 2019-2020 | |
| Valeritas, INC. | $41.26 | 2019 | |
| Shire North American Group INC | $41.03 | 2019 | |
| Gilead Sciences, INC. | $38.10 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $36.50 | 2020 | |
| Becton, Dickinson and Company | $27.24 | 2019-2020 | |
| Insulet Corporation | $26.00 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.84 | 2019-2020 | |
| Ibsa Pharma INC. | $17.95 | 2024 | Tirosint, Licart |
| Cequr Corporation | $14.75 | 2023-2025 | Cequr Simplicity |
| Amneal Pharmaceuticals LLC | $14.11 | 2020 | |
| Glaxosmithkline, LLC. | $14.06 | 2020 | |
| Medtronic Minimed, INC. | $14.00 | 2019 | |
| Therapeuticsmd, INC. | $13.89 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.69 | 2019 | |
| Echosens North America, INC. | $6.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narinder Sandhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.